Supporting Information: Antioxidant, hypotensive, and antidiabetic breakthroughs: Bromelain hydrolysis unlocks quinoa’s peptide potential - In silico and in vitro approach

Figure S1: Different peptides released after the simulated hydrolysis of 11S seed globulin – Chenopodium quinoa (AAS67037.1) – with stem bromelain. Figure S2. Molecular docking, a general view of protein-ligand interactions showing the residues from the active site involved in making the interaction...

Descripción completa

Detalles Bibliográficos
Autores: Manzanilla-Valdez, María Lilibeth, Montaño, Sarita, Martínez-Villaluenga, Cristina, Zúñiga, Fernanda, Boesch, Christine, Hernández-Álvarez, Alan Javier
Tipo de recurso: conjunto de datos
Fecha de publicación:2025
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/410097
Acceso en línea:http://hdl.handle.net/10261/410097
Access Level:acceso abierto
Descripción
Sumario:Figure S1: Different peptides released after the simulated hydrolysis of 11S seed globulin – Chenopodium quinoa (AAS67037.1) – with stem bromelain. Figure S2. Molecular docking, a general view of protein-ligand interactions showing the residues from the active site involved in making the interactions with the ligand (quinoa peptides).Figure S3: Mass spectrum analysis of quinoa-derived peptides (from simulated hydrolysis with stem bromelain) YDDER, NIYQIS, and QDQHQKIR after being chemically synthesized.